RVMDW · Revolution Medicines, Inc. · Documents
$8.85
-0.52 (-5.55%)
At close · Oct 26
Return incl. dividend (before tax)
Market Cap
$40.08B
Shares
214.34M
Volume · Oct 26
18.53K
Avg daily vol (3M)
39.62K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | Following FDA approval of RASONQUE™ (daraxonrasib), Revolution Medicines, Inc. borrowed a $250.0 million Tranche A Loan, paid a $5.0 million draw fee, and declined a potential $250.0 million Tranche 3 payment. | 2026-10-13 | 2026-10-08 | |
| 8-K | — | 2026-09-01 | 2026-08-27 | |
| 8-K | — | 2026-08-26 | — | |
| 8-K | — | 2026-08-05 | — | |
| 10-Q | — | 2026-08-05 | 2026-06-30 | |
| 8-K | — | 2026-06-22 | 2026-06-18 | |
| Investor Event Transcript | — | 2026-05-31 | 2026-06-30 | |
| 10-Q | — | 2026-05-06 | 2026-03-31 | |
| 8-K | — | 2026-05-06 | — | |
| ARS | — | 2026-04-28 | 2025-12-31 | |
| DEFA14A | — | 2026-04-28 | — | |
| DEF 14A | — | 2026-04-27 | 2026-06-18 | |
| 8-K | — | 2026-04-17 | 2026-04-14 | |
| 8-K | — | 2026-04-16 | 2026-04-14 | |
| 8-K | — | 2026-04-13 | — | |
| 10-K | — | 2026-02-25 | 2025-12-31 | |
| 8-K | — | 2026-02-25 | — | |
| 8-K | — | 2025-11-05 | — | |
| 10-Q | — | 2025-11-05 | 2025-09-30 | |
| 8-K | — | 2025-10-17 | 2025-10-16 | |
| 8-K | — | 2025-09-10 | — | |
| 10-Q | — | 2025-08-06 | 2025-06-30 | |
| 8-K | — | 2025-08-06 | — | |
| 8-K | — | 2025-06-27 | 2025-06-26 | |
| 8-K | — | 2025-06-24 | 2025-06-23 | |
| 8-K | — | 2025-06-18 | — | |
| 8-K | — | 2025-05-07 | — | |
| 10-Q | — | 2025-05-07 | 2025-03-31 | |
| DEF 14A | — | 2025-04-29 | 2025-06-26 | |
| ARS | — | 2025-04-29 | 2024-12-31 | |
| DEFA14A | — | 2025-04-29 | — | |
| 10-K | — | 2025-02-26 | 2024-12-31 | |
| 8-K | — | 2025-02-26 | — | |
| 8-K | — | 2024-12-05 | 2024-12-03 | |
| 8-K | — | 2024-12-02 | — | |
| 8-K | — | 2024-11-06 | — | |
| 10-Q | — | 2024-11-06 | 2024-09-30 | |
| 8-K | — | 2024-10-25 | — | |
| 8-K | — | 2024-10-23 | — | |
| 10-Q | — | 2024-08-07 | 2024-06-30 | |
| 8-K | — | 2024-08-07 | 2024-08-05 | |
| 8-K | — | 2024-07-15 | — | |
| 8-K | — | 2024-06-24 | 2024-06-20 | |
| 8-K | — | 2024-05-08 | — | |
| 10-Q | — | 2024-05-08 | 2024-03-31 | |
| S-3ASR | — | 2024-05-08 | — | |
| ARS | — | 2024-04-25 | 2023-12-31 | |
| DEF 14A | — | 2024-04-25 | — | |
| DEFA14A | — | 2024-04-25 | — | |
| S-3ASR | — | 2024-03-04 | — |
Showing 1–50 of 130 filings